The Precision Peptide Company Inc.
CNSXBPC short interest surges 40% in one week to 230,348 shares, while cost to borrow falls to 6.3% and utilization drops to 47%.
Snapshot as of 30 Jun 2026
No long-form analysis yet for BPC. Pulse alerts and the live data picture are available on ORTEX.
Open BPC on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BPC — free to start on ORTEX.
Sign up for free →Open BPC on ORTEX